Trial Profile
An Open-label, Multiple-dosing, Two-arms, One-sequence Study to Evaluate the Safety and Pharmacokinetics After Co-administration of Exforge (Amlodipine Besylate/Valsartan) and Lipitor (Atorvastatin Ca) in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Atorvastatin (Primary)
- Indications Cardiovascular disorders; Diabetic nephropathies; Dyslipidaemias; Hypertension
- Focus Pharmacokinetics
- Sponsors CJ Cheiljedang Corp.; HK inno.N
- 11 Sep 2017 Status changed from not yet recruiting to completed.
- 03 Mar 2014 New trial record